Supplemental information

6 Months Ended

Feb. 28, 2021

Supplemental Cash Flow Elements [Abstract]

Accounts receivable

Accounts receivable are stated net of allowances for doubtful accounts. Accounts receivable balances primarily consist of trade receivables due from customers, including amounts due from third party providers (e.g., pharmacy benefit managers, insurance companies and governmental agencies). Trade receivables were $3.5 billion and $3.0 billion at February 28, 2021 and August 31, 2020, respectively. Other accounts receivable balances, which consist primarily of receivables from vendors and manufacturers, including receivables from AmerisourceBergen (see Note 17 Related parties), were $1.4 billion and $1.1 billion at February 28, 2021 and August 31, 2020, respectively.

Depreciation and amortization

The Company has recorded the following depreciation and amortization expense in the Consolidated Condensed Statements of Earnings (in millions):


	Three months ended				Six months ended
	February 28, 2021		February 29, 2020		February 28, 2021		February 29, 2020
Depreciation expense	$	346	$	359	$	690	$	702
Intangible asset and other amortization	114		98		208		197
Total depreciation and amortization expense	$	460	$	457	$	897	$	898

Accumulated depreciation and amortization on property, plant and equipment was $12.7 billion at February 28, 2021 and $12.1 billion at August 31, 2020.

Restricted cash

The Company is required to maintain cash deposits with certain banks which consist of deposits restricted under contractual agency agreements and cash restricted by law and other obligations.

The following represents a reconciliation of cash and cash equivalents in the Consolidated Condensed Balance Sheets to total cash, cash equivalents and restricted cash in the Consolidated Condensed Statements of Cash Flows as of February 28, 2021 and August 31, 2020 (in millions):


	February 28, 2021		August 31, 2020
Cash and cash equivalents - continuing operations	$	1,030	$	469
Cash and cash equivalents - discontinued operations	68		47
Restricted cash - continuing operations (included in other current assets)	87		62
Restricted cash - discontinued operations	126		168
Cash, cash equivalents and restricted cash	$	1,311	$	746

Redeemable noncontrolling interest

The redeemable noncontrolling interest balance as of February 28, 2021 was $309 million due to acquisitions during the six months period ended February 28, 2021. See Note 3 Acquisitions for further details.

Earnings per share

The dilutive effect of outstanding stock options on earnings per share is calculated using the treasury stock method. Stock options are anti-dilutive and excluded from the earnings per share calculation if the exercise price exceeds the average market price of the common shares. There were 17.1 million weighted outstanding options to purchase common shares that were anti-dilutive and excluded from the second quarter earnings per share calculation as of February 28, 2021 compared to 18.7 million as of February 29, 2020.

Cash dividends declared per common share

Cash dividends per common share declared were as follows:


Quarter ended	2021		2020
November	$	0.4675	$	0.4575
February	$	0.4675	$	0.4575

	$	0.9350	$	0.9150